We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

Roadmap to Successful Therapies for Neurodegenerative Diseases

  • Alzheimer’s disease develops because of a complex series of events that take place in the brain over a long period of time.
  • Today, Alzheimer’s disease is typically diagnosed once symptoms are already clinically present meaning it is often diagnosed at later stages of the disease where irreversible loss of neurons has already occurred. This may go some way to explaining recent research challenges.
  • In response, AC Immune has developed a five point Roadmap to Successful Therapies for Neurodegenerative Diseases. As a strategic leader in the field of neurodegenerative diseases, our Roadmap recognizes the importance of treating earlier, targeting Tau, focusing on more homogeneous populations, precision medicine and exploring neuroinflammation as a target.